The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
Keyword(s):
Keyword(s):
2008 ◽
Vol 14
(7)
◽
pp. 2088-2094
◽
2018 ◽
Vol 41
(6)
◽
pp. 292-299
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 8
(9)
◽
pp. 1190-1195
◽
2014 ◽
Vol 90
(1)
◽
pp. S653